Ireland has established itself as a global leader in the medical technology sector, with 14 of the world’s top 15 Medtech companies maintaining operations in the country. At the heart of this ecosystem is Dublin, home to industry giants such as Medtronic, Abbott, Johnson & Johnson, Boston Scientific, 3M, Goodman, Bausch Health, and many more.
With approximately 450 companies employing around 48,000 professionals, Ireland has the highest number of MedTech employees per capita in Europe. The workforce is set to grow by 3% annually, reaching an estimated 56,000 by 2028.
This concentration of expertise, combined with a regulatory environment and access to global markets, makes Ireland, and Dublin in particular, a strategic location for Medtech innovation, scale, and success.
Why Medtech companies choose Dublin
While companies across a wide range of sectors choose Dublin for its strategic advantages, the region offers a particularly compelling proposition for Medtech firms.
State supports
A key differentiator is the strength of Ireland’s state-backed support ecosystem.
This supportive infrastructure includes a network of research centres funded by Science Foundation Ireland (SFI), which drives both basic and applied research, and Enterprise Ireland, which offers targeted funding and commercialisation support for startups and scaling companies.
For larger enterprises, the Ireland Strategic Investment Fund (ISIF) plays a pivotal role providing capital to help Irish-based companies scale internationally and remain competitive on the global stage.
An ever-growing talent pool
Ireland’s Medtech sector is underpinned by a steadily growing and highly skilled talent pool. Organisations such as the Irish Medtech Association are addressing workforce needs through initiatives such as the Irish MedTech Skillnet, which delivers industry-led training, professional development programmes, and online events tailored to emerging skills demands.
Dublin is also home to a concentration of world-class academic institutions. Trinity College Dublin, University College Dublin (UCD), Dublin City University (DCU) and the Royal College of Surgeons in Ireland (RCSI) all operate leading medical schools with strong ties to teaching hospitals and dedicated accelerator and incubator programmes.

Smart breastfeeding monitor from Dublin-based medTech innovator Coroflo.
An ideal location
As a member of the EU and part of the Eurozone, Ireland serves as a gateway to the €140 billion European MedTech market, the second-largest in the world.
This, coupled with Dublin’s global connectivity, pro-innovation regulatory environment, and leadership in AI adoption, positions the city as a launchpad for companies expanding across Europe and beyond.
A proven track record
Ireland’s exports are now worth more than €16 billion in medical technologies annually. The sector is a global leader in advanced manufacturing, producing 80% of the world’s stents and 75% of orthopaedic knees.
Dublin plays a critical role in this success story as the city combines stability, infrastructure, talent, and a rich life sciences sector making it an enduring choice for global and growth-focused Medtech enterprises.
Startup momentum and growth
Dublin’s Medtech ecosystem is distinguished by its high concentration of R&D activity and innovation-led startups. Approximately 70% of MedTech companies in Ireland are actively engaged in research and development, supported by generous tax incentives, progressive intellectual property regimes, and a range of accelerators and public funding supports.
Irish startup database TechIreland lists more than 200 medtech startups and scale-ups in Dublin alone, representing a significant share of the sector’s total footprint across the island. This mass of innovation is reinforced by strong access to capital. Irish startups across the tech sector have raised €634 million across 79 companies, a record for investment in Ireland
With its deep talent pool and global connectivity, Dublin continues to offer fertile ground for Medtech startups and scaleups.
Promising Medtech companies
Dublin’s Medtech sector is increasingly recognised as a launchpad for world-class health innovation.
Recent standouts include:
- Nuritas, which raised approx. €37 million to scale its AI-powered peptide discovery platform, Magnifier™, which identifies health-boosting ingredients faster than traditional methods.
- STENTiT, a Dutch startup pioneering regenerative vascular implants, won top honours at the 2025 MedTech Innovator Pitch in Dublin. It’s the first company selected for the 2025 Accelerator, spotlighting Dublin’s role in launching even global MedTech success stories.
- Dublin-based CroíValve raised €14.8 million in Series B funding to support U.S. feasibility trials of its non-surgical Duo device for treating tricuspid regurgitation.
- Innovators such as Coroflo (smart breastfeeding monitors), 3D4Medical (AR-powered anatomy platforms), and LetsGetChecked (at-home diagnostic kits) all highlight Dublin’s strength in B2B solutions and consumer-facing healthcare technologies.
Together, these companies reflect the strength and depth of the Medtech ecosystem in Dublin.
Discover why Dublin continues to attract global investment.


